Autor según el artículo: Espineira, S; Flores-Piñas, M; Chafino, S; Viladés, C; Negredo, E; Fernández-Arroyo, S; Mallolas, J; Villar, B; Moreno, S; Vidal, F; Rull, A; Peraire, J
Departamento: Medicina i Cirurgia
Autor/es de la URV: Espineira Vazquez, Sonia / FERNANDEZ ARROYO, SALVADOR / Peraire Forner, José Joaquin / RULL AIXA, ANNA / Vidal Marsal, Francisco / Vilades Laborda, Consuelo Gloria / Villar Navas, Beatriz
Palabras clave: Transcriptomics T-cell-activation Proteomics Plhiv Metabolomics Immunological non-response Genomics transcriptomics risk recovery proteomics plhiv metabolomics infected patients individuals immunological non-response haplogroups cart antiretroviral therapy aids
Resumen: Antiretroviral therapy (ART) induces persistent suppression of HIV-1 replication and gradual recovery of T-cell counts, and consequently, morbidity and mortality from HIV-related illnesses have been significantly reduced. However, in approximately 30% of people living with HIV (PLHIV) on ART, CD4+ T-cell counts fail to normalize despite ART and complete suppression of HIV viral load, resulting in severe immune dysfunction, which may represent an increased risk of clinical progression to AIDS and non-AIDS events as well as increased mortality. These patients are referred to as “immune inadequate responders”, “immunodiscordant responders” or “immune nonresponders (INR)”. The molecular mechanisms underlying poor CD4+ T-cell recovery are still unclear. In this sense, the use of omics sciences has shed light on possible factors involved in the activity and metabolic dysregulation of immune cells during the failure of CD4+ T-cell recovery in INR. Moreover, identification of key molecules by omics approaches allows for the proposal of potential biomarkers or therapeutic targets to improve CD4+ T-cell recovery and the quality of life of these patients. Hence, this review aimed to summarize the information obtained through different omics concerning the molecular factors and pathways associated with the INR phenotype to better understand the complexity of this immunological status in HIV infection.
Áreas temáticas: Zootecnia / recursos pesqueiros Saúde coletiva Química Odontología Nutrição Medicina veterinaria Medicina iii Medicina ii Medicina i Interdisciplinar Immunology and allergy Immunology Farmacia Engenharias iii Engenharias ii Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Ciência de alimentos Biotecnología Biodiversidade
Acceso a la licencia de uso: https://creativecommons.org/licenses/by/3.0/es/
Direcció de correo del autor: beatriz.villar@urv.cat joaquim.peraire@urv.cat consuelo.vilades@urv.cat sonia.espineira@estudiants.urv.cat beatriz.villar@urv.cat francesc.vidal@urv.cat
Identificador del autor: 0000-0001-7808-5479 0000-0002-2991-9593 0000-0002-6692-6186
Fecha de alta del registro: 2024-08-03
Versión del articulo depositado: info:eu-repo/semantics/publishedVersion
Enlace a la fuente original: https://www.frontiersin.org/articles/10.3389/fimmu.2023.1228795/full
URL Documento de licencia: https://repositori.urv.cat/ca/proteccio-de-dades/
Referencia al articulo segun fuente origial: Frontiers In Immunology. 14
Referencia de l'ítem segons les normes APA: Espineira, S; Flores-Piñas, M; Chafino, S; Viladés, C; Negredo, E; Fernández-Arroyo, S; Mallolas, J; Villar, B; Moreno, S; Vidal, F; Rull, A; Peraire, (2023). Multi-omics in HIV: searching insights to understand immunological non-response in PLHIV. Frontiers In Immunology, 14(), -. DOI: 10.3389/fimmu.2023.1228795
DOI del artículo: 10.3389/fimmu.2023.1228795
Entidad: Universitat Rovira i Virgili
Año de publicación de la revista: 2023
Tipo de publicación: Journal Publications